Raymond James Financial
PIII icon

Raymond James Financial’s P3 Health Partners PIII Stock Holding History

Raymond James Financial’s Portfolio PIII Stock Details PIII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-47
Closed -$296 – 6257
2025
Q2 		$296 Buy
+47
New +$367 ﹤0.01% 6739

Other funds holding PIII

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
TFA
Trinity Financial Advisors Columbus, Ohio $389M AUM 20.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial's PIII Position: Q3 2025 in Review

Raymond James Financial sold out of P3 Health Partners (PIII) in Q3 2025, closing a stake of 47 shares — an estimated $296 sold.

Raymond James Financial first reported a position in PIII in Q2 2025 and held it in 1 quarter. The position peaked at $296 in Q2 2025. 15 funds tracked by Wall St. Rank hold PIII as of Q3 2025.

  • Raymond James Financial reported no remaining P3 Health Partners position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 47 P3 Health Partners shares in Q3 2025, an estimated $296.
  • Raymond James Financial first reported a position in P3 Health Partners in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's P3 Health Partners position peaked at $296 in Q2 2025.
  • 15 funds tracked by Wall St. Rank held P3 Health Partners as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.